A Role for Soluble IL-6 Receptor in Osteoarthritis
- PMID: 29276788
- PMCID: PMC5739325
- DOI: 10.3390/jfmk2030027
A Role for Soluble IL-6 Receptor in Osteoarthritis
Abstract
Interleukin-6 (IL-6) is one of several pro-inflammatory cytokines present at elevated levels in the synovial fluid of individuals with confirmed clinical diagnosis of rheumatoid arthritis (RA) and osteoarthritis (OA). The mechanism of action of IL-6 was shown to involve its capacity to interact with a membrane-bound IL-6 receptor (mIL-6Rα), also known as the "classical" IL-6 pathway, or through its interaction with a soluble IL-6 receptor (sIL-6R) termed the "trans-signaling" pathway. Activation of downstream signaling is transduced via these IL-6 receptors and principally involves the Janus Kinase/Signal Transduction and Activators of Transcription (JAK/STAT) signaling pathway that is further regulated by glycoprotein-130 (gp130) interacting with the IL-6/mIL-6R complex. Phosphorylation of STAT proteins via JAK activation facilitates STAT proteins to act as transcription factors in inflammation. However, the biological function(s) of the sIL-6R in human chondrocytes requires further elucidation, although we previously showed that exogenous sIL-6R significantly suppressed the synthesis of neutrophil gelatinase-associated lipocalin (NGAL) in the immortalized line of human chondrocytes, C28/I2. NGAL was shown to regulate the activity of matrix metalloproteinase-9 (MMP-9), whose activity is crucial in OA for the destruction of articular cartilage. The "shedding" of sIL-6R from the plasma membrane is carried out by a family of enzymes known as A Distintegrin and Metalloproteinase (ADAM), which are also elevated in OA. In this paper, we have systematically reviewed the role played by IL-6 in OA. We have proposed that sIL-6R may be an important target for future drug development in OA by ameliorating cartilage extracellular protein degradation.
Keywords: a disintegrin and metalloproteinase; cytokines; inflammation; interleukin-6; interleukin-6 receptor; osteoarthritis; signal transduction.
Conflict of interest statement
Conflicts of Interest: The authors declare no conflict of interest.
Figures
Similar articles
-
Role of interleukin 6 (IL-6)/IL-6R-induced signal tranducers and activators of transcription and mitogen-activated protein kinase/extracellular.J Rheumatol. 2005 Jul;32(7):1307-16. J Rheumatol. 2005. PMID: 15996070
-
IL-6 and soluble IL-6 receptor stimulate the production of MMPs and their inhibitors via JAK-STAT and ERK-MAPK signalling in human chondrocytes.Cell Biol Int. 2012 Apr 1;36(4):367-76. doi: 10.1042/CBI20110150. Cell Biol Int. 2012. PMID: 22087578
-
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.J Bone Miner Res. 1996 Jan;11(1):88-95. doi: 10.1002/jbmr.5650110113. J Bone Miner Res. 1996. PMID: 8770701
-
Interleukin-6: A Masterplayer in the Cytokine Network.Oncology. 2020;98(3):131-137. doi: 10.1159/000505099. Epub 2020 Jan 20. Oncology. 2020. PMID: 31958792 Review.
-
The role of cytokines in osteoarthritis pathophysiology.Biorheology. 2002;39(1-2):237-46. Biorheology. 2002. PMID: 12082286 Review.
Cited by
-
Role of Forkhead Box O Transcription Factors in Oxidative Stress-Induced Chondrocyte Dysfunction: Possible Therapeutic Target for Osteoarthritis?Int J Mol Sci. 2018 Nov 28;19(12):3794. doi: 10.3390/ijms19123794. Int J Mol Sci. 2018. PMID: 30487470 Free PMC article. Review.
-
MicroRNAs and Osteoarthritis.Cells. 2018 Aug 1;7(8):92. doi: 10.3390/cells7080092. Cells. 2018. PMID: 30071609 Free PMC article. Review.
-
The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date.Drug Des Devel Ther. 2021 Jul 6;15:2921-2945. doi: 10.2147/DDDT.S295224. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34262259 Free PMC article. Review.
-
Targeting Soluble Epoxide Hydrolase and Cyclooxygenases Enhance Joint Pain Control, Stimulate Collagen Synthesis, and Protect Chondrocytes From Cytokine-Induced Apoptosis.Front Vet Sci. 2021 Aug 5;8:685824. doi: 10.3389/fvets.2021.685824. eCollection 2021. Front Vet Sci. 2021. PMID: 34422942 Free PMC article.
-
Maackia amurensis seed lectin (MASL) ameliorates articular cartilage destruction and increases movement velocity of mice with TNFα induced rheumatoid arthritis.Biochem Biophys Rep. 2022 Sep 9;32:101341. doi: 10.1016/j.bbrep.2022.101341. eCollection 2022 Dec. Biochem Biophys Rep. 2022. PMID: 36120492 Free PMC article.
References
-
- Denko CW, Malemud CJ. Metabolic disturbances and synovial joint responses in osteoarthritis. Front Biosci. 1999;4:d686–d693. - PubMed
-
- Cicuttini FM, Wluka AE. Osteoarthritis: Is OA a mechanical or systemic disease? Nat Rev Rheumatol. 2014;10:515–516. - PubMed
-
- Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010;6:625–635. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous